Data updated: Mar 29, 2026

NOVELGENIX THERAPS

Immunology

Generics

NOVELGENIX THERAPS is a generic drug manufacturer focused on Immunology.

2018

Since

1

Drugs

-

Trials

21

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

NAPROXEN SODIUM 2026-01-24

NAPROXEN SODIUM 2026-01-24

NAPROXEN SODIUM 2026-01-24

NAPROXEN SODIUM 2026-01-15

NAPROXEN SODIUM 2025-09-16

NAPROXEN SODIUM 2025-09-16

NAPROXEN SODIUM 2025-09-16

NAPROXEN SODIUM 2025-09-16

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

AbbVie big-pharma

Johnson & Johnson big-pharma